Immunomodulators selected from: (a) a saturated or cis-unsaturated CSUB10/SUB-CSUB20 /SUBfatty alcohol or an ester thereof with a CSUB1/SUB-CSUB6 /SUBalkanoic acid; (b) a monoester of a CSUB2/SUB-CSUB8 /SUBalkanediol or of Glycerol with a saturated or cis-unsaturated CSUB10/SUB-CSUB20 /SUBfatty acid; and (c) a diester of glycerol with a saturated or cis-unsaturated CSUB10/SUB-CSUB20 /SUBfatty acid, are useful for treatment of inflammation, particularly immunologically-mediated inflammation such as it occurs in autoimmune diseases.
展开▼
